SEC Form 10-K filed by Walgreens Boots Alliance Inc.
$WBA
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2024 | $23.00 | Market Perform | Leerink Partners |
| 2/20/2024 | Hold → Reduce | HSBC Securities | |
| 1/3/2024 | $21.00 | Underweight | Barclays |
| 12/22/2023 | $27.00 | Hold | HSBC Securities |
| 10/23/2023 | $27.00 → $30.00 | Neutral → Overweight | JP Morgan |
| 7/3/2023 | $37.00 → $27.00 | Underweight | Morgan Stanley |
| 6/28/2023 | $46.00 → $34.00 | Buy → Hold | Deutsche Bank |
| 2/23/2023 | $45.00 | Buy | Loop Capital |
Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the U.S. Walgreens, an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, today announced the appointment of Jason Stenta as SVP and chief commercial officer. In this new role, Stenta will lead the company's commercial growth strategy, driving development and commercialization of B2B healthcare services built on the company's core assets, and enhancing partnerships with payers, health system providers and life sciences companies. This press release features multimedia. View the full release
Names Tracey Koller as Chief Merchandising Officer and Sharmila Sudhakar as Group Vice President and Head of Digital Commerce Walgreens, the leading independent retail pharmacy and healthcare provider, today announced two key leadership appointments: Tracey Koller, senior vice president and chief merchandising officer, and Sharmila Sudhakar, group vice president and head of Walgreens digital commerce. The company believes these new appointments will significantly contribute to its efforts with regard to the turnaround of the business as the company focuses on enhancing the front of store and omnichannel experience for its customers while driving in-store efficiencies. This press release
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Super Micro Computer Inc. (NASDAQ:SMCI), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, July 22, 2024. Super Micro Computer Inc. will replace Walgreens Boots Alliance Inc. (NASDAQ:WBA) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted Index. Walgreens Boots Alliance Inc. will also be removed from the Nasdaq-100 Ex-Tech Sector™ Index (NASDAQ:NDXX), the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG), and the Nasdaq-100 Sustainable ESG Select™ Index (NASDAQ:NDXSES) on the same date. Super Micro Computer Inc
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
Company moves earnings date with Securities and Exchange Commission and U.S. stock markets closed on January 9, the previously scheduled date, in honor of late former President Jimmy Carter Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fiscal year 2025 first quarter results at 7 a.m. ET on Friday, January 10, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The company today announced it is moving the previously scheduled earnings date of January 9 back one day, as the Securities and Exchange Commission and U.S. stock markets will be closed on the 9th in observance of a national day of mourning for former President Jimmy Carter. The
BLOOMINGTON, Minn. and ATLANTA, Dec. 18, 2024 /PRNewswire/ -- CaringBridge, a nonprofit health platform, and Walgreens, an integrated healthcare, pharmacy and retail leader, are proud to announce a two-day campaign when Walgreens will match donations on CaringBridge up to $50,000 on December 17 and 18. The campaign complements a year-round initiative on CaringBridge.TheGiftCardShop.com, an e-commerce website where consumers can purchase and send gift cards directly to caregivers. Since launching gift card options earlier this year, CaringBridge receives 3% of the face value of
The Walgreens Patient Advisory Board will collaborate with the Walgreens Clinical Trials team to provide insights aimed at increasing representation in clinical trials. With a history of more than 120 years serving communities across the country, Walgreens prides itself in being a trusted retail pharmacy partner for more than 9 million patients and customers it serves each day. Walgreens is amplifying its commitment to its patients and partners through the formation of the Walgreens Clinical Trials Patient Advisory Board. Since its launch in June 2022, the Walgreens Clinical Trials team has reached more than 7 million patients to potentially recruit into sponsor-led clinical trials. As th
Leerink Partners initiated coverage of Walgreens Boots Alliance with a rating of Market Perform and set a new price target of $23.00
HSBC Securities downgraded Walgreens Boots Alliance from Hold to Reduce
Barclays initiated coverage of Walgreens Boots Alliance with a rating of Underweight and set a new price target of $21.00
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal
Company moves earnings date with Securities and Exchange Commission and U.S. stock markets closed on January 9, the previously scheduled date, in honor of late former President Jimmy Carter Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fiscal year 2025 first quarter results at 7 a.m. ET on Friday, January 10, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The company today announced it is moving the previously scheduled earnings date of January 9 back one day, as the Securities and Exchange Commission and U.S. stock markets will be closed on the 9th in observance of a national day of mourning for former President Jimmy Carter. The
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fiscal year 2025 first quarter results at 7 a.m. ET on Thursday, January 9, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 175-year heritage of caring for communities. A trusted, global innovator in retail
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on Dec. 12, 2024, to stockholders of record as of Nov. 18, 2024. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 368 straight quarters (92 years). About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with approximately 1
10-Q - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
S-3ASR - Walgreens Boots Alliance, Inc. (0001618921) (Filer)